Thomas Trimarchi
CIK 2030813 · View on SEC EDGAR ↗
First SEC filing: July 29, 2024 · Latest: July 29, 2024
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 21, 2025 | BBIO | S | 42,237 | $49.48 | $2,089,887 | 421,081 Direct | -9.12% | Disposed | 71.2% (price as of 2026-08-19) |
| Aug. 18, 2025 | BBIO | S 10b5-1 | 1,973 | $50.94 | $100,505 | 463,318 Direct | -0.42% | Disposed | 66.3% (price as of 2026-08-19) |
| Aug. 18, 2025 | BBIO | S 10b5-1 | 15,380 | $50.14 | $771,153 | 465,291 Direct | -3.20% | Disposed | 68.9% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 6, 2024 | BBIO | Stock Option (Right to Buy) | Common Stock (3,160) | $24.87 | Aug. 5, 2034 | 3,160 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 29, 2024 | BBIO | Common Stock | 394,856 | Direct |
| July 29, 2024 | BBIO | Stock Option (Right to Buy)→ Common Stock (115,000) | 115,000 | Direct |
| July 29, 2024 | BBIO | Stock Option (Right to Buy)→ Common Stock (16,419) | 16,419 | Direct |
| July 29, 2024 | BBIO | Stock Option (Right to Buy)→ Common Stock (22,145) | 22,145 | Direct |
| July 29, 2024 | BBIO | Stock Option (Right to Buy)→ Common Stock (158,127) | 158,127 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
BBIO
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $675,589 | $525,000 | $4,602,488 | — | — | — | $29,293 | $5,832,369 |
| 2024 | $643,654 | $454,200 | — | — | — | — | $27,558 | $6,502,058 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.